Exenatide, which works by stimulating the pancreas to produce more insulin in response to raised blood sugar, was launched in the UK last week under the brand name Byetta. A chemical in the lizard’s saliva called exendin-4 was shown to act in a similar way to the human hormone glucagon-like-peptide-1 (GLP-1).